Literature DB >> 20556666

Chemoradiotherapy in the treatment of inoperable high-grade osteosarcoma.

Micaela M Hernberg1, Aarne H Kivioja, Tom O Böhling, Rita J Janes, Tom A Wiklund.   

Abstract

Radical surgery is not feasible for all osteosarcoma patients. Overall survival for non-extremity osteosarcoma, as well as for patients with metastatic disease at diagnosis remains poor. For such patients, radical radiotherapy combined with chemotherapy may present an effective treatment approach. This report describes the results of conservative treatment for osteosarcoma patients not suitable for surgery. Seven out of 71 consecutive osteosarcoma patients were treated non-surgically at the Helsinki University Central Hospital either due to the inoperability of the tumour or the patient's choice of therapy. Staging procedures and measurement of tumour size were performed using computed tomography and magnetic resonance imaging. Six patients were treated with chemo-radiotherapy, and one patient received radiotherapy alone. Five patients received computer-assisted dose-planned radiotherapy with curative intent (total dose 60-70.5 Gray), and two patients received radiotherapy as palliation. Radiotherapy relieved symptoms efficiently. Median time to local failure was 2.6 years (range 0.5-16.9+ years). Five year after treatment termination four patients were alive, and one of them remained disease-free. For selected patients not suitable for surgery, radiotherapy combined with chemotherapy provides an option to reduce symptoms caused by the primary tumour and improve quality of life. For some patients, this approach may (even) produce long-term remission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20556666     DOI: 10.1007/s12032-010-9592-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  16 in total

1.  The treatment of osteosarcoma: present trends. The Scandinavian Sarcoma Group experience.

Authors:  O P Solheim; G Saeter; I Elomaa; T A Alvegård
Journal:  Ann Oncol       Date:  1992-04       Impact factor: 32.976

2.  Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.

Authors:  G Bacci; A Briccoli; S Ferrari; A Longhi; M Mercuri; R Capanna; D Donati; S Lari; C Forni; M DePaolis
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

3.  Postoperative radiotherapy in the management of adult soft tissue sarcoma of the extremities: results with two different total dose, fractionation, and overall treatment time schedules.

Authors:  C Le Péchoux; M C Le Deley; S Delaloge; E Lartigau; C Levy-Piedbois; S Bonvalot; A Le Cesne; G Missenard; P Terrier; D Vanel; J Genin; F Fontaine
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-07-01       Impact factor: 7.038

4.  Radiotherapy for local control of osteosarcoma.

Authors:  Thomas F DeLaney; Lily Park; Saveli I Goldberg; Eugen B Hug; Norbert J Liebsch; John E Munzenrider; Herman D Suit
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-02-01       Impact factor: 7.038

5.  Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities.

Authors:  Gennady N Machak; Sergey I Tkachev; Yuriy N Solovyev; Pavel A Sinyukov; Stanislav M Ivanov; Natalya V Kochergina; Alexey D Ryjkov; Valery V Tepliakov; Benjamin Y Bokhian; Valeria V Glebovskaya
Journal:  Mayo Clin Proc       Date:  2003-02       Impact factor: 7.616

6.  Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.

Authors:  Patrick Hundsdoerfer; Marion Albrecht; Ursula Rühl; Rüdiger Fengler; Andreas E Kulozik; Günter Henze
Journal:  Eur J Cancer       Date:  2009-09       Impact factor: 9.162

7.  Neoadjuvant chemotherapy for osteosarcoma of the extremities with metastases at presentation: recent experience at the Rizzoli Institute in 57 patients treated with cisplatin, doxorubicin, and a high dose of methotrexate and ifosfamide.

Authors:  G Bacci; A Briccoli; M Rocca; S Ferrari; D Donati; A Longhi; F Bertoni; P Bacchini; S Giacomini; C Forni; M Manfrini; S Galletti
Journal:  Ann Oncol       Date:  2003-07       Impact factor: 32.976

8.  Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.

Authors:  Anita Mahajan; Shiao Y Woo; David G Kornguth; Dennis Hughes; Winston Huh; Eric L Chang; Cynthia E Herzog; Christopher E Pelloski; Pete Anderson
Journal:  Pediatr Blood Cancer       Date:  2008-05       Impact factor: 3.167

9.  Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.

Authors:  Leo Kager; Andreas Zoubek; Ulrike Pötschger; Ulrike Kastner; Silke Flege; Beate Kempf-Bielack; Detlev Branscheid; Rainer Kotz; Mechthild Salzer-Kuntschik; Winfried Winkelmann; Gernot Jundt; Hartmut Kabisch; Peter Reichardt; Heribert Jürgens; Helmut Gadner; Stefan S Bielack
Journal:  J Clin Oncol       Date:  2003-05-15       Impact factor: 44.544

10.  Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders.

Authors:  S Smeland; C Müller; T A Alvegard; T Wiklund; T Wiebe; O Björk; A E Stenwig; H Willén; T Holmström; G Follerås; O Brosjö; A Kivioja; K Jonsson; O Monge; G Saeter
Journal:  Eur J Cancer       Date:  2003-03       Impact factor: 9.162

View more
  3 in total

Review 1.  Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives.

Authors:  Joaquim Soares do Brito; Miguel Esperança-Martins; André Abrunhosa-Branquinho; Cecilia Melo-Alvim; Raquel Lopes-Brás; João Janeiro; Dolores Lopez-Presa; Isabel Fernandes; José Portela; Luis Costa
Journal:  Cancers (Basel)       Date:  2022-05-22       Impact factor: 6.575

2.  Palliative approach in advanced pelvic osteosarcoma: a single centre experience of a rare disease.

Authors:  Ritesh Kumar; Rakesh Kapoor; Divya Khosla; Narendra Kumar; Pramod Kumar Singh; Mahendra Kumar; Sc Sharma
Journal:  Indian J Palliat Care       Date:  2014-05

3.  Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

Authors:  Kjetil Berner; Kirsten Sundby Hall; Odd R Monge; Harald Weedon-Fekjær; Olga Zaikova; Øyvind S Bruland
Journal:  Sarcoma       Date:  2015-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.